A clinical trial listing was updated on September 1, 2026, showing a new status for a study involving corticorelin. The trial, registered as NCT05277948 and titled "Effect of Thumbtack Needle (TN) on Ovarian Reserve Function of Women With Diminished Ovarian Reserve (DOR)," is classified as not applicable phase. According to the registry entry, the trial status is now listed as COMPLETED. No results have been posted alongside this status update in the data provided. The registry entry does not include outcome data, efficacy claims, or safety findings related to corticorelin or the thumbtack needle intervention. This update reflects only a change in trial status as recorded on ClinicalTrials.gov. Readers should note that a completed status indicates the study has concluded enrollment and procedures, not that results have been published or reviewed. Further details, including any eventual outcome data, would appear in subsequent registry updates or associated publications. For additional context on corticorelin, including its approved regulatory status and general background, readers can consult the compound overview.
Trial Update: Thumbtack Needle Study Referencing Corticorelin Marked Completed
See the full corticorelin overview
Source: https://clinicaltrials.gov/study/NCT05277948